ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 176 filers reported holding ANTARES PHARMA INC in Q2 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,374,000 | +14.8% | 1,310,817 | -0.0% | 0.04% | +18.2% |
| Q4 2021 | $4,681,000 | +358.5% | 1,311,253 | +367.3% | 0.03% | +312.5% |
| Q3 2021 | $1,021,000 | -17.4% | 280,589 | -1.0% | 0.01% | -11.1% |
| Q2 2021 | $1,236,000 | -0.2% | 283,453 | -6.0% | 0.01% | 0.0% |
| Q1 2021 | $1,239,000 | +2.1% | 301,482 | -0.9% | 0.01% | -10.0% |
| Q4 2020 | $1,214,000 | +39.4% | 304,217 | -5.6% | 0.01% | +11.1% |
| Q3 2020 | $871,000 | +9.7% | 322,393 | +11.7% | 0.01% | +12.5% |
| Q2 2020 | $794,000 | +17.5% | 288,623 | +0.9% | 0.01% | 0.0% |
| Q1 2020 | $676,000 | – | 286,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |